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Abstract 
Introduction: Infections caused by Acinetobacter junii are rarely reported. However, some outbreaks of septicemia in neonates and pediatric 
oncology patients, as well as meningitis, peritonitis, and ocular infection have been described. Since it is highly infrequent to find the 
molecular characterization of A. junii strains in literature, in this study we described the molecular characterization of A. junii isolates 
recovered from blood samples of a renal transplant patient.  
Methodology: The case was defined as a catheter-related bacteremia caused by A. junii. The patient responded favorably after catheter 
removal and treatment with ciprofloxacin. 
Results and Conclusion: The complete molecular characterization of the isolate showed that it harbored a class 1 integron and diverse DNA 
mobile elements. This explains its genomic plasticity for acquiring antimicrobial resistance determinants and for adapting to a nosocomial 
niche. 
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Introduction 
Few reports describe Acinetobacter junii infections 
that affect patients who have had prior antibiotic 
therapy, invasive procedures or malignancy [1]. 
However, some outbreaks of septicemia in neonates 
and pediatric oncology patients, as well as meningitis 
[2], peritonitis [3], and ocular infection [4] have been 
described [5-7]. 
In contrast to A. baumannii infections, the 
infections caused by A. junii are easy to treat because 
this bacterium is commonly susceptible to 
antimicrobial agents [5]. Still, carbapenem-resistant A. 
junii producing OXA-type carbapenemases and IMP-4 
have been described [8,9]. The presence of plasmids 
containing antibiotic resistance genes, commonly 
found in A. baumannii, shows that horizontal genetic 
transfer may be possible between both species of 
Acinetobacter. By this genetic exchange the 
therapeutic options to treat A. junii infections might be 
limited. 
Mobile elements and resistance determinants 
associated to antibiotic resistance have been well 
studied for A. baumannii [10-12], in contrast there are 
few reports of these elements in A. junii [13,14]. 
Genetically characterized A. junii strains is rarely 
described in literature. This study was undertaken to 
investigate whether A. junii can be a reservoir of 
mobile elements. In addition, we studied the 
occurrence of resistant determinants in A. junii which 
had previously been described in A. baumannii isolates 





Positive growth were obtained in two blood culture 
sets (taken at two different moments) and in the blood 
culture drawn through the catheter hub (BacT/Alert; 
bioMérieux, Marcy l’Etoile, France) from a 41 years 
old female patient. She was admitted to the hospital 
for pathological fracture of the left tibia secondary to 
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brown tumor. She had a history of papillary thyroid 
carcinoma and renal transplant in 2006 treated with 
tacrolimus and corticosteroids since that date. 
The isolates were analyzed using VITEK 2 
Compact (bioMérieux, Marcy l’Etiole, France) system. 
Polymrase chain reaction (PCR) amplifications and 
sequence analysis of the 16S rRNA and rpoB genes 
were carried out to confirm the identification [15]. 
Sequencing was performed on both DNA strands 
using ABIPrism 3100 BioAnalyzer equipment for 




The antibiotic susceptibility test was performed 
using the VITEK 2 System (bioMerieux, Marcy, 
L’Etoile, France) employing the panel AST-082 (GNS 
susceptibility card). The minimum inhibitory 
concentration (MIC) results were interpreted using the 




Total DNA of the A. junii isolates was prepared 
and used as template for PCR reactions. PCR reactions 
were carried out using the GoTaq enzyme according to 
manufacturer’s instructions (Promega, Madison, 
USA), and the products were detected by agarose gel 
electrophoresis. To reveal the presence of resistance 
determinants against different antibiotics families 
(tet(A), tet(B), blaADC, blaOXA-23, blaOXA-51, blaOXA-58, 
blaCTXM-2, blaSHV, blaVEB, qnrB, qnrS, aadB, aacC2, 
aac(6’)-Ib, aadA1, aphA1, sul1, sul2, sul3, strA, strB, 
dfr18, dfr9, dfr20, floR), mobile elements (IncP, IncW, 
IncA/C, IncN, IncFII, pRAY, Tn1331, Tn3, IS26, 
IS440, ISAba1, ISAba125, IS1008, ISCR2, AbaR-type 
resistance island), and integrons, specific primers were 
used [17,18,19,20,21] . 
All positive PCR amplification products were 
sequenced on both DNA strands, using an ABI 
Prism3100 BioAnalyzer equipment (Macrogen Inc., 
Seoul, Republic of South Korea) and nucleotide 
sequences were analyzed using the Blast v2.0 software 
(http://www.ncbi.nlm.nih.gov/BLAST/). 
 
Results and Discussion 
In the recovered isolates the bionumber obtained 
using the Vitek system was 0040000100500100, 
which gives an identification of Acinetobacter junii 
with 98 % probability. To confirm the identification, 
16S RNA and rpoB gene amplifications were 
conducted. Sequence analysis revealed a 99% identity 
with the sequences corresponding to the 16S  
ribosomal RNA gene of A. junii (Accession number 
JX840368) and 100 % of identity with RNA 
polymerase subunit B (rpoB) gene of A. junii 
(Accession number JQ924568). Both isolates were 
susceptible to ampicillin/sulbactam ( 2 µg/ml); 
piperacillin-tazobactam ( 4 µg/ml), ceftazidime (4 
µg/ml), cefepime ( 2 µg/ml);  carbapenems (imipenem 
 1 µg/ml; meropenem  0.25 µg/ml ), ciprofloxacin 
( 0.25 µg/ml ) rifampicin (0,19 µg/ml) and colistin ( 
0.5 µg/ml) and resistant to gentamicin ( 16 µg/ml); 
amikacin ( 64  µg/ml); and TMP-SMX ( 4 µg/ml).  
Due to the fact there is little information published 
on the molecular mechanisms and mobile elements 
associated to antimicrobial resistance in A. junii, we 
decided to study the resistance determinants and 
mobile elements based on their wide distribution in 
our country [22,19]. 
Among the PCR reactions carried out to detect 
resistance determinants, positive results were only 
obtained for sul1, sul2, strA, strB, aphA1 and aac(6’)-
Ib (Table 1), which explained the resistance found in 
the strains to gentamicin, amikacin and TMP-SMX. 
The mobile elements found in the A. junii isolates 
were the insertion sequences IS26, ISAba1, ISAba125, 
IS1008 and ISCR2, which is in agreement with the 
high occurrence of insertion sequences in 
Acinetobacter spp. [12,13]. Negative results were 
obtained to determine the presence not only of 
plasmids belonging to the incompatibility plasmids 
tested in this study, but also of transposons mostly 
present in our clinical isolates. 
We observed the presence of one class 1 integron, 
whereas we obtained negative results for class 2 
integron amplification, which is the most wide-spread 
class of integron in our A. baumannii strains in our 
region. The amplification of the variable region (vr-1) 
of the integron revealed the presence of the gene 
cassettes arr3-aac(6’)-Ib, genes that codify for a 
rifampin ADP-ribosylating transferase and an 
aminoglycoside-(6')-N-acetyltransferase, respectively.  
The association between the IS26 and the aphA1 
gene, encoding for APH (3’)-I aminoglycoside 
phosphotransferase enzyme and conferring kanamycin 
and neomycin resistance, is frequent in A. baumannii 
strains [23,24]. Thus we decided to test the association 
of these two genes in our strain obtaining positive 
results for the amplification reactions carried out. This 
result showed that in A. junii, the aphA1 gene can also 
be linked with IS26 as it was described for A. 
baumannii.  
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Concerning the phenotype of these strains, the 
presence of the aac(6’)-Ib gene, can explain the 
observed resistance to amikacin. However, no 
resistance to rifampicin was observed suggesting that 
the arr3 gene cassettes maybe weakly expressed or do 
not confer resistance to our strains. 
The molecular characterization of the A. junii 
isolates showed the presence of different mobile 
genetic elements and determinants associated to 
horizontal gene transfer; these elements might also 
play an important role in the acquisition and 
development of antibiotic resistance in this species.  
Infections caused by species of Acinetobacter 
other than A. baumannii have been reported in 
literature [25,15]. The existence of molecular 
techniques that allow correct species identification 
give an important contribution to the epidemiology of 
non- baumannii Acinetobacter and to the knowledge 
on the real prevalence of these species and the type of 
infections associated with them. In addition, 
information regarding the antimicrobial resistance 
mechanisms and mobile genetics elements contained 
in these species can help to establish a more accurate 
treatment and stop their spreading.  
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